SC
BSX icon

Sapient Capital’s Boston Scientific BSX Stock Holding History

Sapient Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,141
Closed -$574K – 409
2026
Q1 		$574K Sell
9,141
-115,431
-93% -$9.23M 0.01% 254
2025
Q4 		$12M Sell
124,572
-2,017
-2% -$198K 0.17% 83
2025
Q3 		$12.3M Sell
126,589
-1,449
-1% -$150K 0.19% 80
2025
Q2 		$13.8M Sell
128,038
-7,568
-6% -$766K 0.25% 70
2025
Q1 		$13.7M Buy
135,606
+622
+0.5% +$62.6K 0.27% 69
2024
Q4 		$12.1M Buy
134,984
+964
+0.7% +$84.9K 0.23% 72
2024
Q3 		$11.2M Sell
134,020
-4,191
-3% -$330K 0.23% 70
2024
Q2 		$10.6M Sell
138,211
-993
-0.7% -$72.7K 0.22% 72
2024
Q1 		$9.53M Sell
139,204
-1,218
-0.9% -$78.3K 0.21% 79
2023
Q4 		$8.12M Buy
+140,422
New +$7.5M 0.21% 80

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Sapient Capital's BSX Position: Q2 2026 in Review

Sapient Capital sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 9,141 shares — an estimated $574K sold.

Sapient Capital first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $13.8M in Q2 2025. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sapient Capital reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Sapient Capital sold 9,141 Boston Scientific shares in Q2 2026, an estimated $574K.
  • Sapient Capital first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • Sapient Capital's Boston Scientific position peaked at $13.8M in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.